exoVACC

N/A

Report date: 2025/01/26 17:02:56

Base Information

Drug NameexoVACC
Drug Alias Nameengineered exosome-delivered vaccine (Codiak Biosciences)exosome-based vaccine (Codiak Biosciences)
ClassificationBiologics > ExosomesVaccines > Application > Prophylactic vaccine
Mechanisms of ActionB cells modulatorsT lymphocytes modulatorsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Nerve DegenerationNeoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodiak BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Ragon Institute of MGHCodiak BioSciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Nerve DegenerationNeoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A